Page 42 - Sample Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana

REDLANDS, Calif. - May 14, 2021 - (Newswire.com) Climet Instruments Company, a Division of Venturedyne Ltd, (herein 'Climet') the leading manufacturer of high quality cleanroom particle counters and microbial samplers, today announced the introduction of their CI-97 microbial air sampler. Climet Instruments Company is very proud to announce the introduction of the CI-97 microbial air sampler. What makes the CI-97 unique is the light ring, which is user configurable in five colors and a selection of display patterns that indicate operational status and alarms. Also, sample...

According to Coherent Market Insights, the U.K. drug for abuse testing devices market is estimated to be valued at US$ 275.7 million in 2020 and is expected to exhibit a CAGR of 5.0% during the forecast

by Sample Type (Blood, Embryo, Ovum, and Semen) and End User (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical & Biotech Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global medical thawing system market size garnered $165.82 million in 2019, and is projected to garner $279.17 million by 2027, registering a CAGR of 11.6% from 2020 to 2027. Prime determinants of growth Rise in incidents of chronic disease, technical advancement that have eased thawing, increase in awareness and government initiative towards the plasma...

Thawing System Market to Witness Comprehensive Growth by 2026 Global Thawing System Market was valued US$ 140.2 Mn in 2017 and is expected to reach US$ 342.5 Mn by 2026, at a CAGR of 11.81 % during a forecast period. BriefingWire.com, 5/07/2021 - Global Thawing System Market was valued US$ 140.2 Mn in 2017 and is expected to reach US$ 342.5 Mn by 2026, at a CAGR of 11.81 % during a forecast period. Thawing systems are used for melting biological samples such as plasma, stem cells, whole blood & RBC, platelets in diagnostic centers, biobanks, ph...

Services segment expected to grow at the highest CAGR during the forecast period. Based on service and product, the drug screening market is segmented into services and products. Services segment accounted for the largest share of the market in 2019. This segment is also expected to register the highest CAGR during the forecast period, mainly due to the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new service launches, and regulatory approvals, and geographic expansion of drug and alcohol testing laboratories. Analytical instruments are ex...